IGF-1R fluorescent antibody binding to pancreatic cancer cells and tumors is specific, as shown by Western blotting of IGF-1R binding to the cancer cell membranes (Figure 1) by the much greater antibody-derived fluorescence, compared to non-specific autofluorescence, and in orthotopic as well as subcutaneous tumors seen by both microscopic as well as endoscopic-like imaging devices, and by histological experiments which showed that the antibody specifically binds to tumor tissue (Figure 4). This evidence concerns the gene IGF1R and pancreatic neoplasm.